DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Weinstein C, Jordan K, Green S. et al.
Abstract P6-11-11: Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer receiving moderately emetogenic chemotherapy regimens.
Cancer Res 2018;
78: P6-11-11-P16-11-11
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.